ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Wisconsin » Infectious Disease

Top Infectious Disease Prescribers in Wisconsin

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
ROBERT GULLBERG MD

Infectious Disease

15,048

$992K

702
563 are 65+

6%
patients receiving schedule two controlled substances

Avg: 2%

14%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 42%

$66
Average prescription price

Avg: $255

LINDA SEALE MD

Infectious Disease

5,568

$302K

287
241 are 65+

12%
patients receiving schedule two controlled substances

Avg: 2%

10%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 42%

$54
Average prescription price

Avg: $255

JOHN FANGMAN MD

Infectious Disease

5,474

$2.12M

115
0 are 65+

22%
patients receiving schedule two controlled substances

Avg: 2%

21%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

51%
prescriptions for brand name drugs

Avg: 42%

$388
Average prescription price

Avg: $255

RICHARD REICH MD

Infectious Disease

3,567

$381K

220
165 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

8%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 42%

$107
Average prescription price

Avg: $255

KEITH KONKOL MD

Infectious Disease

3,408

$258K

137
102 are 65+

10%
patients receiving schedule two controlled substances

Avg: 2%

13%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

18%
prescriptions for brand name drugs

Avg: 42%

$76
Average prescription price

Avg: $255

WILLIAM AGGER MD

Infectious Disease

2,028

$255K

135
102 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 42%

$126
Average prescription price

Avg: $255

SYLVIA FIRARY MD

Infectious Disease

1,600

$287K

93
57 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

13%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

31%
prescriptions for brand name drugs

Avg: 42%

$180
Average prescription price

Avg: $255

MARY BETH GRAHAM MD

Infectious Disease

1,587

$934K

130
33 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

67%
prescriptions for brand name drugs

Avg: 42%

$588
Average prescription price

Avg: $255

BRIAN BUGGY M.D.

Infectious Disease

1,530

$647K

104
66 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

47%
prescriptions for brand name drugs

Avg: 42%

$423
Average prescription price

Avg: $255

BENNETT VOGELMAN MD

Infectious Disease

1,392

$602K

42
14 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

54%
prescriptions for brand name drugs

Avg: 42%

$432
Average prescription price

Avg: $255

SHEETAL KANDIAH MD

Infectious Disease

1,281

$710K

91
21 are 65+

16%
patients receiving schedule two controlled substances

Avg: 2%

16%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

51%
prescriptions for brand name drugs

Avg: 42%

$554
Average prescription price

Avg: $255

THOMAS SELL MD

Infectious Disease

1,276

$315K

142
104 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

30%
prescriptions for brand name drugs

Avg: 42%

$247
Average prescription price

Avg: $255

IRAM NADEEM MD

Infectious Disease

1,154

$608K

56
18 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

61%
prescriptions for brand name drugs

Avg: 42%

$527
Average prescription price

Avg: $255

ROBERT NOYCE MD

Infectious Disease

1,140

$420K

88
57 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

42%
prescriptions for brand name drugs

Avg: 42%

$369
Average prescription price

Avg: $255

CHARLES BRUMMITT M.D.

Infectious Disease

1,099

$434K

82
47 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

53%
prescriptions for brand name drugs

Avg: 42%

$395
Average prescription price

Avg: $255

MICHAEL FRANK MD

Infectious Disease

1,081

$838K

50
11 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

83%
prescriptions for brand name drugs

Avg: 42%

$775
Average prescription price

Avg: $255

CHRISTINE HOGAN M.D.

Infectious Disease

1,076

$454K

48
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

52%
prescriptions for brand name drugs

Avg: 42%

$422
Average prescription price

Avg: $255

DENNIS MAKI MD

Infectious Disease

1,060

$159K

51
39 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

18%
prescriptions for brand name drugs

Avg: 42%

$150
Average prescription price

Avg: $255

DAVID LETZER MD

Infectious Disease

942

$362K

116
82 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

41%
prescriptions for brand name drugs

Avg: 42%

$384
Average prescription price

Avg: $255

ANDREW URBAN MD

Infectious Disease

900

$675K

39
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

78%
prescriptions for brand name drugs

Avg: 42%

$750
Average prescription price

Avg: $255

RAY HASELBY DO

Infectious Disease

835

$50.7K

85
66 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 42%

$61
Average prescription price

Avg: $255

NEENA THOMAS-GOSAIN M.D.

Infectious Disease

820

$513K

44
14 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

59%
prescriptions for brand name drugs

Avg: 42%

$626
Average prescription price

Avg: $255

BARBARA LAUDERDALE MD

Infectious Disease

814

$271K

55
41 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

46%
prescriptions for brand name drugs

Avg: 42%

$333
Average prescription price

Avg: $255

JAMES LEVIN MD

Infectious Disease

710

$779K

92
47 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

59%
prescriptions for brand name drugs

Avg: 42%

$1097
Average prescription price

Avg: $255

ANDREW PETROLL MD

Infectious Disease

663

$443K

49
19 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

61%
prescriptions for brand name drugs

Avg: 42%

$669
Average prescription price

Avg: $255

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank